⌘K

Login Start Free

Home/Filings/4/0001415889-25-009632

4//SEC Filing

Stuart Iain 4

Accession 0001415889-25-009632

CIK 0001566044other

View on SEC.gov Company Profile

Filed

Apr 1, 8:00 PM ET

Accepted

Apr 2, 4:15 PM ET

Size

5.1 KB

Accession

0001415889-25-009632

Insider Transaction Report

Form 4

Period: 2025-03-31

VYNE Therapeutics Inc.VYNE

CHIEF SCIENTIFIC OFFICER

Transactions

Tax Payment
Common Stock
2025-03-31$1.58/sh−6,044$9,550→ 122,593 total

Footnotes (1)

[F1]Represents shares that have been withheld by the Issuer to satisfy tax withholding requirements in connection with the vesting of restricted stock units.

Documents

1 file

4
form4-04022025_040413.xmlPrimary

Issuer

VYNE Therapeutics Inc.

CIK 0001566044

Entity typeother

Related Parties

1

filerCIK 0001727756

Filing Metadata

Form type: 4
Filed: Apr 1, 8:00 PM ET
Accepted: Apr 2, 4:15 PM ET
Size: 5.1 KB

View on SEC.gov